iminosugar (Baruch S Blumberg Institute)

N/A

Report date: 2025/01/26 19:01:17
NME

Base Information

Drug Nameiminosugar (Baruch S Blumberg Institute)
Drug Alias NameCOVID19 spike glycoprotein inhibitor (Baruch S Blumberg Institute)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaruch S. Blumberg Institute
China Registration ClassN/A

Develop Information

Active CompaniesBaruch S. Blumberg Institute
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A